Abstract

BackgroundTo assess the effectiveness of emergency vaccination for reducing the contact-induced infection and pathological damage caused by the highly pathogenic porcine reproductive and respiratory syndrome virus (HPPRRSV), Twenty pigs were equally divided into four groups. Groups 1, 2 and 3 were housed in one unit, whereas Group 4 was separately housed. Group 1 was challenged with HPPRRSV on day 0. Group 2 and 4 did not receive treatment and were used as the contact-infected and uninfected controls, respectively. Group 3 was treated with the attenuated vaccine at 0 days post-inoculation. The rectal temperatures, clinical signs, pathologic lesions and viraemia of the piglets were detected and evaluated.ResultsThe vaccinated pigs in Group 3 showed less clinical morbidity, viraemia, temperature fluctuations and lung lesions at 14 days post-inoculation, as compared with the contact-infected (Group 2) and experimentally infected (Group 1) pigs. Higher serum IFN-γ levels were detected among the pigs that received emergency immunisation. Thus, IFN-γ may be involved in immunity against HPPRRSV infection.ConclusionsThese results indicated that emergency vaccination could effectively alleviate HPPRRSV infection during experimental contact exposure. Our findings provide a novel and useful strategy for controlling clinical HPPRRSV.

Highlights

  • To assess the effectiveness of emergency vaccination for reducing the contact-induced infection and pathological damage caused by the highly pathogenic porcine reproductive and respiratory syndrome virus (HPPRRSV), Twenty pigs were divided into four groups

  • This study aimed to replicate clinical cases under experimental conditions to confirm the effects of emergency immunisation, which may be widely used for emergency cases of HPPRRSV infection

  • Aside from the high fever, the appearance of typical HPPRRSV-induced characteristics was delayed for almost eight days in Group 3

Read more

Summary

Introduction

To assess the effectiveness of emergency vaccination for reducing the contact-induced infection and pathological damage caused by the highly pathogenic porcine reproductive and respiratory syndrome virus (HPPRRSV), Twenty pigs were divided into four groups. Group 3 was treated with the attenuated vaccine at 0 days post-inoculation. The highly pathogenic porcine reproductive and respiratory syndrome virus (HPPRRSV) in China was first reported in 2006; the outbreak overwhelmed ten provinces (including autonomous cities or regions) with more than 2,000,000 infected pig within the first four months [1]. An HPPRRSV-derived attenuated vaccine was developed to control the disease [3]. The attenuated vaccine of a modified-live virus (MLV) derived from the American PRRSV VR-2332 has been widely used in PRRSV-prevalent countries, with its safety and effectiveness proven by previous studies [4,5].

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call